A Family Affected by a Life-Threatening Erythrocyte Defect Caused by Pyruvate Kinase Deficiency With Normal Iron

Karolina Maciak1, Anna Adamowicz-Salach2, Jaroslaw Poznanski1

  • 1Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.

Frontiers in Genetics
|November 16, 2020
PubMed

Insights

Red cell pyruvate kinase deficiency (PKD) causes severe anemia. This study identified new mutations in a Polish family and found they lack iron overload due to a hepcidin-independent mechanism, despite frequent transfusions.

Area of Science:

  • Genetics
  • Hematology
  • Biochemistry

Background:

  • Red cell pyruvate kinase deficiency (PKD) is an inherited metabolic disorder affecting glycolysis, leading to congenital non-spherocytic hemolytic anemia.
  • PKD presents with variable clinical severity, ranging from mild anemia to life-threatening conditions requiring lifelong transfusions and risking iron overload.

Purpose of the Study:

  • To investigate the genetic basis of severe hemolytic anemia in a Polish family.
  • To explore the mechanisms of iron regulation in transfusion-dependent patients with PKD.

Main Methods:

  • Whole exome sequencing to identify genetic mutations.
  • Molecular modeling to assess the impact of mutations on PKLR protein structure and function.
  • Analysis of iron levels and hepcidin in patient serum.

Main Results:

  • Identified two heterozygous mutations (c.1529 G > A and c.1495 T > C) in the PKLR gene in affected family members.
  • Molecular modeling indicated significant disruption of PKLR protein structure and function.
  • Patients were homozygous for TMPRSS6 variant rs855791 and showed undetectable hepcidin levels without signs of iron overload despite frequent transfusions.

Conclusions:

  • The findings suggest a hepcidin-independent mechanism prevents iron overload in transfusion-dependent PKD patients.
  • This highlights a novel aspect of iron regulation in the context of severe hemolytic anemia.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
581
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
166.9K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.4K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
4.8K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
4.0K